Strategic Acquisition WIL Research was acquired by Charles River Laboratories in 2016 for approximately 585 million dollars, indicating strong market validation and increased resources that can be leveraged to expand service offerings and client engagement globally.

Global Footprint With laboratories across North America and Europe, as well as international sales offices, WIL Research offers extensive geographic coverage, making it an ideal partner for clients seeking localized support in various regions.

Specialized Services The company's expertise in toxicology, safety pharmacology, regulatory compliance, and bioanalytical research presents opportunities to target pharmaceutical, biotech, and chemical companies requiring advanced safety testing and clinical support.

Market Positioning As part of one of the largest CROs with a revenue range of 100 to 250 million dollars, WIL Research is positioned to attract mid-size and large clients looking for tailored research solutions in competitive markets.

Technology Usage Utilizing advanced tech stacks such as Hotjar, Couchbase, and Scala, WIL Research demonstrates an innovation-driven approach, appealing to clients interested in cutting-edge research methodologies and digital engagement.